Terms: = Colorectal cancer AND TPR, P12270, 7175 AND Treatment
11 results:
1. Correcting rotational error in rectal cancer radiation therapy: Can planning target volume margins be safely reduced?
Seah V; Dundas K; Hudson F; Surjan Y; Bartlett R; Ko R; Smith S; Arumugam S; Johnston M; Wong K; Lee M
J Med Radiat Sci; 2022 Dec; 69(4):473-483. PubMed ID: 35715996
[TBL] [Abstract] [Full Text] [Related]
2. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Antoniotti C; Rossini D; Pietrantonio F; Catteau A; Salvatore L; Lonardi S; Boquet I; Tamberi S; Marmorino F; Moretto R; Ambrosini M; Tamburini E; Tortora G; Passardi A; Bergamo F; Kassambara A; Sbarrato T; Morano F; Ritorto G; Borelli B; Boccaccino A; Conca V; Giordano M; Ugolini C; Fieschi J; Papadopulos A; Massoué C; Aprile G; Antonuzzo L; Gelsomino F; Martinelli E; Pella N; Masi G; Fontanini G; Boni L; Galon J; Cremolini C;
Lancet Oncol; 2022 Jul; 23(7):876-887. PubMed ID: 35636444
[TBL] [Abstract] [Full Text] [Related]
3. KATZLDA: KATZ measure for the lncRNA-disease association prediction.
Chen X
Sci Rep; 2015 Nov; 5():16840. PubMed ID: 26577439
[TBL] [Abstract] [Full Text] [Related]
4. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
[TBL] [Abstract] [Full Text] [Related]
5. The subcellular distribution and function of MTA1 in cancer differentiation.
Liu J; Xu D; Wang H; Zhang Y; Chang Y; Zhang J; Wang J; Li C; Liu H; Zhao M; Lin C; Zhan Q; Huang C; Qian H
Oncotarget; 2014 Jul; 5(13):5153-64. PubMed ID: 24970816
[TBL] [Abstract] [Full Text] [Related]
6. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.
Pomerleau V; Landry M; Bernier J; Vachon PH; Saucier C
BMC Cancer; 2014 Apr; 14():240. PubMed ID: 24708867
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy.
Yonemura Y; Canbay E; Ishibashi H
ScientificWorldJournal; 2013; 2013():978394. PubMed ID: 23710154
[TBL] [Abstract] [Full Text] [Related]
8. Total perineal reconstruction after abdominoperineal excision for rectal cancer: long-term results of dynamic graciloplasty with Malone appendicostomy.
Abbes Orabi N; Vanwymersch T; Paterson HM; Mauel E; Jamart J; Crispin B; Kartheuser A
Colorectal Dis; 2011 Apr; 13(4):406-13. PubMed ID: 20041927
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
[TBL] [Abstract] [Full Text] [Related]
10. Absence of cancer diagnosis and treatment in elderly Medicaid-insured nursing home residents.
Bradley CJ; Clement JP; Lin C
J Natl Cancer Inst; 2008 Jan; 100(1):21-31. PubMed ID: 18159068
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience.
Thomas PR; Lindblad AS
Radiother Oncol; 1988 Dec; 13(4):245-52. PubMed ID: 3064191
[TBL] [Abstract] [Full Text] [Related]
